Prognostic Values of Transforming Growth Factor‐Beta Subtypes in Ovarian Cancer

Abstract

Higher expression of TGF-<i>β</i>2 functioned as a significant predictor of poor prognosis in women with ovarian cancer, especially those with TP53 mutations or who were undergoing chemotherapy with platins, Taxol, or a platin+Taxol.